Delivering Value To Those We Serve

Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018

October 8, 2018 at 7:00 AM EDT

LAKE FOREST, Ill., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8, 2018, after the close of markets. Following the announcement, the Company will host a conference call beginning at 4:30 p.m. ET to discuss its results.

Participants can access the live webcast from the Investor Relations section of Assertio's website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.

Audio Conference Call:
U.S. Dial-in Number: 1-844-839-0046
International Dial-in Number:  1-857-270-6032
Conference ID: 2462479

An archived webcast replay will be available on the Company's website accessed by visiting http://investor.assertiotx.com.

About Assertio Therapeutics, Inc.
Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. To learn more about Assertio, visit www.assertiotx.com.

Investor and Media Contact:
John B. Thomas
Senior Vice President, Investor Relations and Corporate Communications
jthomas@assertiotx.com 

 

Assertio Logo.jpg

Source: Assertio Therapeutics, Inc.